158 related articles for article (PubMed ID: 31537867)
1. Identification of differentially expressed genes and fusion genes associated with malignant progression of spinal cord gliomas by transcriptome analysis.
Liu DK; Wang J; Guo Y; Sun ZX; Wang GH
Sci Rep; 2019 Sep; 9(1):13583. PubMed ID: 31537867
[TBL] [Abstract][Full Text] [Related]
2. Screening critical genes associated with malignant glioma using bioinformatics analysis.
Xu Y; Wang J; Xu Y; Xiao H; Li J; Wang Z
Mol Med Rep; 2017 Nov; 16(5):6580-6589. PubMed ID: 28901452
[TBL] [Abstract][Full Text] [Related]
3. High frequency of H3F3A (K27M) mutations characterizes pediatric and adult high-grade gliomas of the spinal cord.
Gessi M; Gielen GH; Dreschmann V; Waha A; Pietsch T
Acta Neuropathol; 2015 Sep; 130(3):435-7. PubMed ID: 26231952
[No Abstract] [Full Text] [Related]
4. Spinal cord high-grade infiltrating gliomas in adults: clinico-pathological and molecular evaluation.
Alvi MA; Ida CM; Paolini MA; Kerezoudis P; Meyer J; Barr Fritcher EG; Goncalves S; Meyer FB; Bydon M; Raghunathan A
Mod Pathol; 2019 Sep; 32(9):1236-1243. PubMed ID: 31028365
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of genome-wide DNA methylation, gene expression and protein expression profiles in molecular subtypes of WHO II-IV gliomas.
Wang ZL; Zhang CB; Cai JQ; Li QB; Wang Z; Jiang T
J Exp Clin Cancer Res; 2015 Oct; 34():127. PubMed ID: 26502731
[TBL] [Abstract][Full Text] [Related]
6. An integrated transcriptomic and computational analysis for biomarker identification in human glioma.
Xing W; Zeng C
Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173
[TBL] [Abstract][Full Text] [Related]
7. Low-grade spinal glioneuronal tumors with BRAF gene fusion and 1p deletion but without leptomeningeal dissemination.
Chiang JCH; Harreld JH; Orr BA; Sharma S; Ismail A; Segura AD; Ellison DW
Acta Neuropathol; 2017 Jul; 134(1):159-162. PubMed ID: 28547128
[No Abstract] [Full Text] [Related]
8. Identification of hub genes related to prognosis in glioma.
Zhang D; Zhao J; Han C; Liu X; Liu J; Yang H
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32406502
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Markers Identification in Glioma by Gene Expression Profile Analysis.
Hu G; Wang R; Wei B; Wang L; Yang Q; Kong D; Du C
J Comput Biol; 2020 Jan; 27(1):81-90. PubMed ID: 31433208
[TBL] [Abstract][Full Text] [Related]
10. Microarray analysis of the aberrant microRNA expression pattern in gliomas of different grades.
Zhu XP; Mou KJ; Xu QF; Tang JH; Huang GH; Xu JP; Li GH; Ai SJ; Hugnot JP; Zhou Z; Lv SQ
Oncol Rep; 2015 Jul; 34(1):318-24. PubMed ID: 25954994
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatic Profiling of Prognosis-Related Genes in Malignant Glioma Microenvironment.
Li Y; Deng G; Qi Y; Zhang H; Gao L; Jiang H; Ye Z; Liu B; Chen Q
Med Sci Monit; 2020 Aug; 26():e924054. PubMed ID: 32843610
[TBL] [Abstract][Full Text] [Related]
12. The promising novel biomarkers and candidate small molecule drugs in lower-grade glioma: Evidence from bioinformatics analysis of high-throughput data.
Zhang B; Wu Q; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Wang Z; Zhou YL
J Cell Biochem; 2019 Sep; 120(9):15106-15118. PubMed ID: 31020692
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor receptor (PDGFR) expression in primary spinal cord gliomas.
Ellis JA; Canoll P; McCormick PC; Feldstein NA; Anderson RC; Angevine PD; Kaiser MG; McCormick PC; Bruce JN; Ogden AT
J Neurooncol; 2012 Jan; 106(2):235-42. PubMed ID: 21789698
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional network analysis reveals that AT1 and AT2 angiotensin II receptors are both involved in the regulation of genes essential for glioma progression.
Azevedo H; Fujita A; Bando SY; Iamashita P; Moreira-Filho CA
PLoS One; 2014; 9(11):e110934. PubMed ID: 25365520
[TBL] [Abstract][Full Text] [Related]
15. A blood-based gene expression and signaling pathway analysis to differentiate between high and low grade gliomas.
Ponnampalam SN; Kamaluddin NR; Zakaria Z; Matheneswaran V; Ganesan D; Haspani MS; Ryten M; Hardy JA
Oncol Rep; 2017 Jan; 37(1):10-22. PubMed ID: 28004117
[TBL] [Abstract][Full Text] [Related]
16. Integrated mRNAseq and microRNAseq data analysis for grade III gliomas.
Dai J; Bing Z; Zhang Y; Li Q; Niu L; Liang W; Yuan G; Duan L; Yin H; Pan Y
Mol Med Rep; 2017 Nov; 16(5):7468-7478. PubMed ID: 28944855
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome-wide Sequencing Reveals Molecules and Pathways Involved in Neurofibromatosis Type I Combined With Spinal Deformities.
Cai S; Yang Y; Jia B; Wu Z; Zhang J; Shen J; Qiu G
Spine (Phila Pa 1976); 2020 May; 45(9):E489-E498. PubMed ID: 31770328
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes of radiotherapy for primary spinal cord glioma.
Choi SH; Yoon HI; Yi S; Park JW; Cho J; Shin DA; Ha Y; Kim DS; Kim SH; Lee SK; Chang JH; Suh CO
Strahlenther Onkol; 2019 Feb; 195(2):164-174. PubMed ID: 30203111
[TBL] [Abstract][Full Text] [Related]
19. Significance of H3K27M Mutation in "Nonmidline" High-Grade Gliomas of Cerebral Hemispheres.
La Rocca G; Sabatino G; Altieri R; Signorelli F; Ricciardi L; Gessi M; Della Pepa GM
World Neurosurg; 2019 Nov; 131():174-176. PubMed ID: 31415896
[TBL] [Abstract][Full Text] [Related]
20. Microarray data analysis to identify crucial genes regulated by CEBPB in human SNB19 glioma cells.
Du C; Pan P; Jiang Y; Zhang Q; Bao J; Liu C
World J Surg Oncol; 2016 Oct; 14(1):258. PubMed ID: 27716259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]